Biology:mir-145
Generic protein structure example |
mir-145 | |
---|---|
Conserved secondary structure of mir-145 | |
Identifiers | |
Symbol | mir-145 |
Rfam | RF00675 |
miRBase family | MIPF0000079 |
Other data | |
RNA type | microRNA |
Domain(s) | Eukaryota; |
PDB structures | PDBe |
In molecular biology, mir-145 microRNA is a short RNA molecule that in humans is encoded by the MIR145 gene. MicroRNAs function to regulate the expression levels of other genes by several mechanisms.[1]
Targets
MicroRNAs are involved in down-regulation of a variety of target genes. Götte et al. have shown that experimental over-expression of mir-145 down-regulates the junctional cell adhesion molecule JAM-A as well as the actin bundling protein fascin in breast cancer and endometriosis cells, resulting in a reduction of cell motility.[2][3] Larsson et al.[4] showed that miR-145 targets the 3' UTR of the FLI1 gene, a finding that was later supported by Zhang et al.[5]
Role in cancer
miR-145 is hypothesised to be a tumor suppressor.[6] miR-145 has been shown to be down-regulated in breast cancer.[3] miR-145 is also involved in colon cancer [5][7][8] and acute myeloid leukemia.[9]
References
- ↑ "Entrez Gene: MicroRNA 145". https://www.ncbi.nlm.nih.gov/gene/406937.
- ↑ Adammek, Marlene (2013). "MicroRNA miR-145 inhibits proliferation, invasiveness, and stem cell phenotype of an in vitro endometriosis model by targeting multiple cytoskeletal elements and pluripotency factors.". Fertility and Sterility 99 (5): 1346–1355.e5. doi:10.1016/j.fertnstert.2012.11.055. PMID 23312222.
- ↑ 3.0 3.1 "miR-145-dependent targeting of junctional adhesion molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness". Oncogene 29 (50): 6569–80. Dec 2010. doi:10.1038/onc.2010.386. PMID 20818426.
- ↑ "Discovery of microvascular miRNAs using public gene expression data: miR-145 is expressed in pericytes and is a regulator of Fli1". Genome Medicine 1 (11): 108. 2009. doi:10.1186/gm108. PMID 19917099.
- ↑ 5.0 5.1 "Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene Friend leukemia virus integration 1 gene". Cancer 117 (1): 86–95. Jan 2011. doi:10.1002/cncr.25522. PMID 20737575.
- ↑ "p53 represses c-Myc through induction of the tumor suppressor miR-145". Proceedings of the National Academy of Sciences of the United States of America 106 (9): 3207–12. Mar 2009. doi:10.1073/pnas.0808042106. PMID 19202062.
- ↑ "Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer". Oncology 72 (5–6): 397–402. 2007. doi:10.1159/000113489. PMID 18196926.
- ↑ Mazza, Tommaso; Mazzoccoli, Gianluigi; Fusilli, Caterina; Capocefalo, Daniele; Panza, Anna; Biagini, Tommaso; Castellana, Stefano; Gentile, Annamaria et al. (2016-05-19). "Multifaceted enrichment analysis of RNA-RNA crosstalk reveals cooperating micro-societies in human colorectal cancer". Nucleic Acids Research 44 (9): 4025–4036. doi:10.1093/nar/gkw245. ISSN 1362-4962. PMID 27067546.
- ↑ "Genome-wide identification of human microRNAs located in leukemia-associated genomic alterations". Blood 117 (2): 595–607. Jan 2011. doi:10.1182/blood-2010-03-277012. PMID 20962326. http://www.bloodjournal.org/content/117/2/595?sso-checked=true.
Further reading
- "MiR-145, a new regulator of the DNA fragmentation factor-45 (DFF45)-mediated apoptotic network". Molecular Cancer 9: 211. 2010. doi:10.1186/1476-4598-9-211. PMID 20687965.
- "The functional significance of microRNA-145 in prostate cancer". British Journal of Cancer 103 (2): 256–64. Jul 2010. doi:10.1038/sj.bjc.6605742. PMID 20588276.
- "miR-145-mediated suppression of cell growth, invasion and metastasis". American Journal of Translational Research 2 (2): 170–80. 2010. PMID 20407606.
- "miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma". International Journal of Cancer 127 (12): 2804–14. Dec 2010. doi:10.1002/ijc.25284. PMID 21351259.
- "miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer". British Journal of Cancer 102 (5): 883–91. Mar 2010. doi:10.1038/sj.bjc.6605570. PMID 20160723.
- Kudla, Grzegorz, ed (2010). "MicroRNA-145 targets YES and STAT1 in colon cancer cells". PLOS ONE 5 (1): e8836. doi:10.1371/journal.pone.0008836. PMID 20098684.
- "MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1". Cancer Research 70 (1): 378–87. Jan 2010. doi:10.1158/0008-5472.CAN-09-2021. PMID 19996288.
- "Discovery of microvascular miRNAs using public gene expression data: miR-145 is expressed in pericytes and is a regulator of Fli1". Genome Medicine 1 (11): 108. 2009. doi:10.1186/gm108. PMID 19917099.
- "miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors". Oncogene 29 (7): 1073–84. Feb 2010. doi:10.1038/onc.2009.395. PMID 19915607.
- "Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype". Nature Medicine 16 (1): 49–58. Jan 2010. doi:10.1038/nm.2054. PMID 19898489.
- "Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer". BMC Cancer 9: 374. 2009. doi:10.1186/1471-2407-9-374. PMID 19843336.
- "MicroRNA-145 in vascular smooth muscle cell biology: a new therapeutic target for vascular disease". Cell Cycle 8 (21): 3469–73. Nov 2009. doi:10.4161/cc.8.21.9837. PMID 19829088.
- "miR-145 directs intestinal maturation in zebrafish". Proceedings of the National Academy of Sciences of the United States of America 106 (42): 17793–8. Oct 2009. doi:10.1073/pnas.0903693106. PMID 19805048.
- "miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells". Cell Death and Differentiation 17 (2): 246–54. Feb 2010. doi:10.1038/cdd.2009.117. PMID 19730444.
- "MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury". Genes & Development 23 (18): 2166–78. Sep 2009. doi:10.1101/gad.1842409. PMID 19720868.
- "miR-145 and miR-143 regulate smooth muscle cell fate and plasticity". Nature 460 (7256): 705–10. Aug 2009. doi:10.1038/nature08195. PMID 19578358.
- "MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation". Circulation Research 105 (2): 158–66. Jul 2009. doi:10.1161/CIRCRESAHA.109.197517. PMID 19542014.
- "Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation". European Journal of Cancer 45 (12): 2197–206. Aug 2009. doi:10.1016/j.ejca.2009.04.039. PMID 19493678.
- "Abate and switch: miR-145 in stem cell differentiation". Cell 137 (4): 606–8. May 2009. doi:10.1016/j.cell.2009.04.059. PMID 19450510.
- "MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells". Cell 137 (4): 647–58. May 2009. doi:10.1016/j.cell.2009.02.038. PMID 19409607.
- "Mechanism of growth inhibition by MicroRNA 145: the role of the IGF-I receptor signaling pathway". Journal of Cellular Physiology 220 (2): 485–91. Aug 2009. doi:10.1002/jcp.21796. PMID 19391107.
- "miR-145 inhibits breast cancer cell growth through RTKN". International Journal of Oncology 34 (5): 1461–6. May 2009. doi:10.3892/ijo_00000275. PMID 19360360.
- "miRNA-145 targets v-ets erythroblastosis virus E26 oncogene homolog 1 to suppress the invasion, metastasis, and angiogenesis of gastric cancer cells". Molecular Cancer Research 11 (2): 182–93. Feb 2013. doi:10.1158/1541-7786.MCR-12-0534. PMID 23233482.
External links
Original source: https://en.wikipedia.org/wiki/Mir-145.
Read more |